Authors

Yingsi(Vincy) Fang, PharmD, BSC

Fang is a PGY- 2 infectious diseases pharmacy resident at Beth Israel Deaconess Medical Center in Boston, Massachusetts, who is interested in infectious diseases in immunocompromised and underserved populations.

Latest Article

Do We Have New Data for Optimal Treatments of Candida-Related Prosthetic Joint Infections?

The choice between debridement and implant exchange affects treatment outcomes for Candida-related prosthetic joint infections, highlighting the need for standardized guidelines and further research.

Judy Luong, PharmD candidate

Luong is a PharmD candidate at Saint Joseph's University in Philadelphia, Pa.

Latest Article

2025 American Thoracic Society Clinical Practice Guideline Updates for the Diagnosis and Management of Community-Acquired Pneumonia

The 2025 ATS guidelines for community-acquired pneumonia update recommendations on imaging, antibiotic use, treatment duration, and corticosteroid use, emphasizing lung ultrasound as an alternative diagnostic tool, more selective empiric antibiotic prescribing, shorter courses of antibiotics for stable patients, and limited use of corticosteroids to severe inpatient cases.

Tina Zheng, PharmD, BCIDP

Zheng, PharmD, BCIDP, is an infectious diseases clinical pharmacist at Maimonides Medical Center.
(https://orcid.org/0009-0005-6107-4657)

Latest Article

Unlocking New Defenses: The Changing Landscape of Candida auris Management

Candida auris is a highly drug-resistant, hospital-acquired fungal pathogen. With limited treatment options, here is an overview of some of the next-generation antifungals as well as combination therapeutics.

Laura Walters, DO

Walters is in her final year of infectious disease fellowship at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. She has an interest in HIV, addiction medicine, and transplant infectious diseases.

Latest Article

Tuberculosis Meningitis in an Immunocompetent Patient

Read more about the case of a 71-year-old man who was admitted after presenting with cold-like symptoms for 3 weeks.

MJ Kasten, MD

Kasten is a consultant in infectious diseases at the Mayo Clinic in Rochester, Minnesota, and serves as medical director for Aliveness and Thrive, a Minneapolis-based HIV advocacy organization and free clinic. A founding member of the HIV clinic at Mayo, she is deeply committed to educating trainees and primary care providers on the care of people living with HIV and strategies for HIV prevention.

Latest Article

Aging in HIV: A Review of Common Comorbidities in People Living With HIV

This review highlights how people living with HIV are living longer due to antiretroviral therapy but face unique age-related health challenges, including cardiovascular disease, metabolic syndrome, renal dysfunction, neurocognitive decline, immunosenescence, bone loss, and frailty, requiring tailored screening and management strategies.

Mohammed Al Musawa, PharmD, BCIDP

Postdoctoral Fellow at Wayne State University

Latest Article

Impact of Obesity on Antibiotic Treatment Outcomes

Presented at MAD-ID by Mohammed Al Musawa, PharmD, BCIDP, the study found lower clinical success with imipenem-cilastatin-relebactam in obese patients, raising questions about dosing strategies.

Peter G. Collin, MD

Collin is a second-year infectious diseases fellow at Beth Israel Deaconess Medical Center.

Latest Article

Ocular Syphilis and Neurosyphilis in a Patient Living With HIV